Join to view full profile
875 Blake Wilbur DrMC 5847Palo Alto, CA 94304
Phone+1 650-723-6171
Fax+1 650-725-8231
Dr. Gensheimer is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonResidency, Radiation Oncology, 2011 - 2015
Johns Hopkins UniversityInternship, Internal Medicine, 2010 - 2011
Vanderbilt University School of MedicineClass of 2010
Certifications & Licensure
CA State Medical License 2015 - 2028
WA State Medical License 2011 - 2015
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017
Clinical Trials
- Radical RADiotherapy and Immunotherapy for Metastatic CAncer of the Lung (RRADICAL) Start of enrollment: 2017 Jun 28
Publications & Presentations
PubMed
- Evaluation of the ESMO-magnitude of clinical benefit scale version 2.0 for the definitive treatment of HPV positive oropharynx cancer with radiation therapy.Yugmel S Nijjar, Eli Sapir, Benjamin W Corn, Michael F Gensheimer
Oral Oncology. 2026-08-01 - Incidence of Named Nerve Perineural Invasion in High-Risk Cutaneous Squamous Cell Carcinoma Treated With Mohs Micrographic Surgery at a Single Academic Institution.Kimiya Aframian, Johanny Lopez Dominquez, Michael Gensheimer, Kelsey Hirotsu
Dermatologic Surgery. 2026-05-27 - Genetic and Immunohistochemical Profiling of Malignant Mesothelioma With Brain Metastasis: A Report of Two Cases.Paul M Harary, Yusuke S Hori, Ruchit Jain, Ahed H Kattaa, Melanie Hayden Gephart
Cancer Reports. 2026-05-01
Press Mentions
Stanford Medicine First to Try Out Novel Tumor-Targeting Radiation Therapy MachineAugust 24th, 2023- RSNA 2022 Plenaries Highlight Radiology’s Value, Responsibility to PatientsJuly 19th, 2022
- Tumor Volume-Adapted RT Leads to Good Lung Cancer Control with Low ToxicityNovember 2nd, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
